Cargando…
A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
BACKGROUND: In inflamed tissue, immune cells are accumulated, and various intercellular signals are involved in the pathogenesis. Janus kinases (JAKs) are typical tyrosine kinases involved in mediating the signaling of multiple cytokines and growth factors and induce the transcription of molecules r...
Autor principal: | Tanaka, Yoshiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826760/ https://www.ncbi.nlm.nih.gov/pubmed/36617565 http://dx.doi.org/10.1186/s41232-022-00253-3 |
Ejemplares similares
-
The rationale for Janus kinase inhibitors for the treatment of spondyloarthritis
por: Veale, Douglas J, et al.
Publicado: (2019) -
Role of janus kinase inhibitors in the treatment of alopecia areata
por: Triyangkulsri, Korn, et al.
Publicado: (2018) -
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review
por: Qi, Fei, et al.
Publicado: (2021) -
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach
por: Tanaka, Yoshiya, et al.
Publicado: (2022) -
Janus kinase inhibitors: jackpot or potluck?
por: Pavithran, Keechilat, et al.
Publicado: (2012)